Gene · 5341
Papers3,086
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,086
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation. | PeerJ | 2019 | 31249732 | PubTator, text mining | PubMed |
| Structure of the Cdc48 segregase in the act of unfolding an authentic substrate. | Science | 2019 | 31249134 | PubTator, text mining | PubMed |
| Phosphatidylinositol Kinases and Phosphatases in Entamoeba histolytica. | Front Cell Infect Microbiol | 2019 | 31245297 | PubTator, text mining | PubMed |
| Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease. | Front Immunol | 2019 | 31244862 | PubTator, text mining | PubMed |
| Immunization with a recombinant antigen composed of conserved blocks from TSA56 provides broad genotype protection against scrub typhus. | Emerg Microbes Infect | 2019 | 31237478 | PubTator, text mining | PubMed |
| Impaired Glycoprotein VI-Mediated Signaling and Platelet Functional Responses in CD45 Knockout Mice. | Thromb Haemost | 2019 | 31226719 | PubTator, text mining | PubMed |
| Elevated telomere dysfunction in cells containing the African-centric Pro47Ser cancer-risk variant of TP53. | Oncotarget | 2019 | 31217894 | PubTator, text mining | PubMed |
| Lowe syndrome-linked endocytic adaptors direct membrane cycling kinetics with OCRL in Dictyostelium discoideum. | Mol Biol Cell | 2019 | 31216233 | PubTator, text mining | PubMed |
| Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology. | PLoS Comput Biol | 2019 | 31206508 | PubTator, text mining | PubMed |
| Correction: Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers. | PLoS Comput Biol | 2019 | 31188819 | PubTator, text mining | PubMed |
| Overexpression of EPAC2 reduces the invasion of glioma cells via MMP-2. | Oncol Lett | 2019 | 31186720 | PubTator, text mining | PubMed |
| Identification of a 13-gene-based classifier as a potential biomarker to predict the effects of fluorouracil-based chemotherapy in colorectal cancer. | Oncol Lett | 2019 | 31186717 | PubTator, text mining | PubMed |
| PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. | J Exp Clin Cancer Res | 2019 | 31182136 | PubTator, text mining | PubMed |
| PLEKHO1 knockdown inhibits RCC cell viability in vitro and in vivo, potentially by the Hippo and MAPK/JNK pathways. | Int J Oncol | 2019 | 31180521 | PubTator, text mining | PubMed |
| Coding or Noncoding, the Converging Concepts of RNAs. | Front Genet | 2019 | 31178900 | PubTator, text mining | PubMed |
| RGD-independent binding of Russell's Viper venom Kunitz-type protease inhibitors to platelet GPIIb/IIIa receptor. | Sci Rep | 2019 | 31165757 | PubTator, text mining | PubMed |
| LncRNA H19 regulates PI3K-Akt signal pathway by functioning as a ceRNA and predicts poor prognosis in colorectal cancer: integrative analysis of dysregulated ncRNA-associated ceRNA network. | Cancer Cell Int | 2019 | 31164794 | PubTator, text mining | PubMed |
| Esculetin, a Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on PLCγ2-PKC-AKT Activation in Human Platelets. | Int J Mol Sci | 2019 | 31163690 | PubTator, text mining | PubMed |
| A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. | Nat Commun | 2019 | 31160568 | PubTator, text mining | PubMed |
| CNIT: a fast and accurate web tool for identifying protein-coding and long non-coding transcripts based on intrinsic sequence composition. | Nucleic Acids Res | 2019 | 31147700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5341/papers?page=50